Filtered By:
Condition: SARS

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 1917 results found since Jan 2013.

COVID-19 lockdown, personal protective equipment, hyper-hygiene and allergy
Eur Ann Allergy Clin Immunol. 2022 Jan 26. doi: 10.23822/EurAnnACI.1764-1489.243. Online ahead of print.ABSTRACTAt the beginning of Sars-Cov 2 pandemic, in the absence of "targeted" therapies, the national health authorities have introduced some measures aimed at reducing the spread of infection in the community (lockdown, social distancing, personal protective equipment (PPE), personal hygiene and disinfection of living environments). All the containment measures have led to both positive and negative effects in patients with allergic diseases. We believe that further studies should be undertaken to investigate the possib...
Source: European Annals of Allergy and Clinical Immunology - January 26, 2022 Category: Allergy & Immunology Authors: G Liccardi M B Bil ò M Milanese M Martini G Pane A De Maio P Rogliani Source Type: research

When Can Immunotherapy for Insect Sting Allergy Be Stopped?
Publication date: May–June 2015 Source:The Journal of Allergy and Clinical Immunology: In Practice, Volume 3, Issue 3 Author(s): Ulrich R. Müller , Johannes Ring Background Stings by Hymenoptera (honey bees, vespids, ants) can cause systemic allergic reactions (SARs). Venom immunotherapy (VIT) is highly effective and reduces an allergic patient's risk of a recurrent SAR to less than 5-20%. The risk of a recurrent SAR to a re-sting decreases the longer VIT is continued. The recommended duration of VIT is at least 3 to 5 years. Risk factors Risk factors for recurrent SARs to a sting after stopping VIT have been identif...
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 5, 2015 Category: Allergy & Immunology Source Type: research

Compounds derived from epigallocatechin-3-gallate (EGCG) as a novel approach to the prevention of viral infections.
Abstract Pathogenic viral infections pose major health risks to humans and livestock due to viral infection-associated illnesses such as chronic or acute inflammation in crucial organs and systems, malignant and benign lesions. These lead to large number of illnesses and deaths worldwide each year. Outbreaks of emerging lethal viruses, such as Ebola virus, severe acute respiratory syndrome (SARS) virus and Middle East respiratory syndrome (MERS) virus, could lead to epidemics or even pandemics if they are not effectively controlled. Current strategies to prevent viral entry into the human body are focused on clean...
Source: Inflammation and Allergy Drug Targets - October 22, 2015 Category: Allergy & Immunology Authors: Hsu S Tags: Inflamm Allergy Drug Targets Source Type: research

Overcoming severe adverse reactions to venom immunotherapy by using anti ‐IgE antibodies in combination with a high maintenance dose
ConclusionsCombining a temporary omalizumab therapy with an elevated maintenance dose seems a promising approach to achieve a tolerance of treatment in patients with a recurrent SAR to VIT.This article is protected by copyright. All rights reserved.
Source: Clinical and Experimental Allergy - August 1, 2017 Category: Allergy & Immunology Authors: Eva Stretz, Eva Maria Oppel, R äwer Helen‐Caroline, René Chatelain, Sebastian Mastnik, Bernhard Przybilla, Franziska Ruëff Tags: Original Article ‐Clinical Allergy Source Type: research

Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
Underlying respiratory allergy and experimental allergen exposure reduce the expression of the SARS-CoV-2 receptor, ACE2, which could lead to reduced COVID-19 susceptibility.
Source: Journal of Allergy and Clinical Immunology - April 21, 2020 Category: Allergy & Immunology Authors: Daniel J. Jackson, William W. Busse, Leonard B. Bacharier, Meyer Kattan, George T. O ’Connor, Robert A. Wood, Cynthia M. Visness, Stephen R. Durham, David Larson, Stephane Esnault, Carole Ober, Peter J. Gergen, Patrice Becker, Alkis Togias, James E. Ger Source Type: research

Rhinologic Procedures in the Era of COVID-19: Health-care Provider Protection Protocol.
CONCLUSION: According to our proposed protocol, we were able to provide care for all patients in clinic, hospital, emergent, intensive, and surgical settings with no transmission of SARS-CoV-2 by symptomatology and post evaluation testing. PMID: 32408753 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - May 13, 2020 Category: ENT & OMF Authors: Taha MA, Hall CA, Rathbone RF, Corsten LA, Bowie CR, Waguespack PJ, Stanger R, Stevenson MM, Zito BA, Barham HP Tags: Am J Rhinol Allergy Source Type: research

Drug allergy labeling and delabeling in the coronavirus disease 2019 era
At the time of this writing, April 7, 2020, more than 1.2 million people worldwide are infected and more than 68,000 have died because of coronavirus disease 2019 (COVID-19) induced by the novel severe acute respiratory syndrome coronavirus 2 infection, and this figure will surely multiply in the next few weeks according to Dr Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases. Severe acute respiratory syndrome coronavirus 2 uses angiotensin-converting enzyme-2 (ACE-2) (a type I transmembrane metallocarboxypeptidase) as its preferred entry receptor.
Source: Annals of Allergy, Asthma and Immunology - May 22, 2020 Category: Allergy & Immunology Authors: Mariana C. Castells Tags: Editorial Source Type: research

Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
Abstract The new virus SARS-CoV-2 is savagely spreading out over the world. The biologic studies show that the target receptor for the virus might be angiotensin-converting enzyme 2 (ACE2). This peptide is responsible for converting angiotensin II (Ang II), which is a profoundly active peptide, into Ang 1-7 with quite a balancing barbell function. It is emphasized that the direct target of the virus is ACE2 underlining the obvious difference with ACE. Nevertheless, we hypothesized that a back load build up effect on Ang II may usurp the ACE capacity and subsequently leave the bradykinin system unabated. We think t...
Source: Iranian Journal of Allergy, Asthma and Immunology - May 16, 2020 Category: Allergy & Immunology Authors: Ghahestani SM, Mahmoudi J, Hajebrahimi S, Sioofy-Khojine AB, Salehi-Pourmehr H, Sadeghi-Ghyassi F, Mostafaei H Tags: Iran J Allergy Asthma Immunol Source Type: research

Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Abstract No Abstract. PMID: 32534505 [PubMed - as supplied by publisher]
Source: Iranian Journal of Allergy, Asthma and Immunology - May 16, 2020 Category: Allergy & Immunology Authors: Dastan F, Abedini A, Shahabi S, Kiani A, Saffaei A, Zare A Tags: Iran J Allergy Asthma Immunol Source Type: research

The show must go on. The impacts of SARS-CoV-2 pandemic on cutaneous allergology and patch testing.
Authors: Alpalhão M, Filipe P PMID: 32729314 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - July 31, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
CONCLUSION: In light of these unprecedented times, the need to understand the nuances of these viral respiratory pathogens, especially SARS-CoV-2, cannot be overemphasized. This knowledge base is of particular importance to otolaryngologists, whose expertise in the upper airway coincides with the anatomic tropism of these infectious agents. PMID: 32762250 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - August 5, 2020 Category: ENT & OMF Authors: Yuen E, Gudis DA, Rowan NR, Nguyen SA, Schlosser RJ Tags: Am J Rhinol Allergy Source Type: research

Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection.
PMID: 32911055 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - September 6, 2020 Category: Allergy & Immunology Authors: Calderón JL, Martin PB, Rodriguez RG, Cataldi HC, Sánchez CS Tags: Ann Allergy Asthma Immunol Source Type: research

Quantification of Aerosol Particle Concentrations During Endoscopic Sinonasal Surgery in the Operating Room.
CONCLUSION: Drilling and microdebrider use during endonasal surgery in a standard operating room is associated with a significant increase in airborne particle concentrations. Fortunately, this increase in aerosol concentration is localized to the area of the operating surgeon, with no detectable increase in aerosol particles at other OR positions. PMID: 33012174 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - October 3, 2020 Category: ENT & OMF Authors: Murr A, Lenze NR, Brown WC, Gelpi MW, Ebert CS, Senior BA, Thorp BD, Zanation AM, Kimple AJ Tags: Am J Rhinol Allergy Source Type: research

Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic.
Authors: Allegra A, Asero R, Giovannetti A, Isola S, Gangemi S Abstract Summary: Urticaria is a condition involving both skin and mucosal tissues characterized by the presence of wheals and/or angioedema. The acute form has been related to allergic reactions to drugs or foods, interaction with chemicals, or infections. We reviewed the association of urticaria with coronavirus infections. This review was carried out by the use of two search engines for published original articles, employing two key terms correlated to urticaria and viruses: "urticaria" and one term linked to each virus. The research of the relations...
Source: European Annals of Allergy and Clinical Immunology - October 11, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

P401 patient satisfaction with telemedicine services in allergy: an institutional survey
This study investigates patient satisfaction with telemedicine services during the SARS-CoV2 pandemic.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2020 Category: Allergy & Immunology Authors: K. Lanier, M. Kuruvilla, J. Shih Source Type: research